Updating the infection risk reduction hierarchy: preventing transition into injection
- PMID: 15047779
- PMCID: PMC3456135
- DOI: 10.1093/jurban/jth083
Updating the infection risk reduction hierarchy: preventing transition into injection
Abstract
Current approaches to prevention of blood-borne infections in injection drug users include referral to drug abuse treatment, access to sterile syringes, bleach disinfection of injection equipment, and education about not sharing equipment. However, rates of some blood-borne infections (e.g., hepatitis C virus) remain elevated among injection drug users, especially early after initiation into injection drug use. With lower infection rates in noninjectors and transition into injection drug use occurring most commonly among these noninjectors, prevention of transition into injection drug use as an additional step to reduce risk for acquisition and transmission of blood-borne infections merits closer attention.
References
-
- US Public Health Service. HIV prevention bulletin: medical advice to persons who inject illicit drugs. May 9, 1997. Available at: http://www.cdc.gov/idu/pubs/hiv_prev.htm. Accessed October 5, 2003.
-
- Vlahov D, Munoz A, Anthony JC, Cohn S, Celentano DD, Nelson KE. Association of drug injection patterns with antibody to human immunodeficiency virus type 1 among intravenous drug users in Baltimore, Maryland. Am J Epidemiol. 1990;132:847–856. - PubMed
-
- Jarlais DC, Friedman SR. HIV infection among intravenous drug users: epidemiology and risk reduction. AIDS. 1987;1:67–76. - PubMed
-
- Johnson J, Williams ML. A preliminary ethnographic decision tree model of injection drug users’ (IDUs) needle sharing. Int J Addict. 1993;28:997–1014. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
